CIP2A and acute pancreatitis: Inhibiting CIP2A expression with TD52 and ethoxysanguinarine decreased the release of inflammatory cytokines, reduced macrophage apoptosis, promoted macrophage autophagy regulation, and inhibited the Akt-mTOR pathway in an in vitro model of acute pancreatitis [63].